Wongwatana S, Leao JC, Scully C, Porter S. Oxpentifylline is not effective for symptomatic oral lichen planus.
J Oral Pathol Med 2005;
34:106-8. [PMID:
15641990 DOI:
10.1111/j.1600-0714.2004.00278.x]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND
There are no reliably effective therapies for oral lichen planus (OLP). The aim of the present work was to determine the potential efficacy of oxpentifylline in the management of OLP.
METHODS
Fifteen patients (six males, median age for the group 52 years, ranging from 33 to 72) with clinically and histopathologically confirmed OLP were treated with oxpentifylline at a dose of 400 mg three times daily.
RESULTS
Only 10 patients completed an 8 week course, the other five having to stop therapy because of adverse effects. Only three patients had any relief of their signs and symptoms of OLP.
CONCLUSION
The results indicate that oxpentifylline is unlikely to be of benefit for the treatment of OLP.
Collapse